Cite
Mwanga-Amumpaire J, Carroll RW, Baudin E, et al. Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical Trial. Open Forum Infect Dis. 2015;2(3):ofv111doi: 10.1093/ofid/ofv111.
Mwanga-Amumpaire, J., Carroll, R. W., Baudin, E., Kemigisha, E., Nampijja, D., Mworozi, K., Santorino, D., Nyehangane, D., Nathan, D. I., De Beaudrap, P., Etard, J. F., Feelisch, M., Fernandez, B. O., Berssenbrugge, A., Bangsberg, D., Bloch, K. D., Boum, Y., & Zapol, W. M. (2015). Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical Trial. Open forum infectious diseases, 2(3), ofv111. https://doi.org/10.1093/ofid/ofv111
Mwanga-Amumpaire, Juliet, et al. "Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical Trial." Open forum infectious diseases vol. 2,3 (2015): ofv111. doi: https://doi.org/10.1093/ofid/ofv111
Mwanga-Amumpaire J, Carroll RW, Baudin E, Kemigisha E, Nampijja D, Mworozi K, Santorino D, Nyehangane D, Nathan DI, De Beaudrap P, Etard JF, Feelisch M, Fernandez BO, Berssenbrugge A, Bangsberg D, Bloch KD, Boum Y, Zapol WM. Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical Trial. Open Forum Infect Dis. 2015 Jul 24;2(3):ofv111. doi: 10.1093/ofid/ofv111. eCollection 2015 Sep. PMID: 26309894; PMCID: PMC4542141.
Copy
Download .nbib
